508 related articles for article (PubMed ID: 27914211)
21. Circulating microRNAs as emerging cardiac biomarkers responsive to acute exercise.
de Gonzalo-Calvo D; Dávalos A; Fernández-Sanjurjo M; Amado-Rodríguez L; Díaz-Coto S; Tomás-Zapico C; Montero A; García-González Á; Llorente-Cortés V; Heras ME; Boraita Pérez A; Díaz-Martínez ÁE; Úbeda N; Iglesias-Gutiérrez E
Int J Cardiol; 2018 Aug; 264():130-136. PubMed ID: 29776561
[TBL] [Abstract][Full Text] [Related]
22. MicroRNAs in Coronary Heart Disease: Ready to Enter the Clinical Arena?
Cavarretta E; Frati G
Biomed Res Int; 2016; 2016():2150763. PubMed ID: 27882321
[TBL] [Abstract][Full Text] [Related]
23. The Role of microRNA in the Development, Diagnosis, and Treatment of Cardiovascular Disease: Recent Developments.
Wronska A
J Pharmacol Exp Ther; 2023 Jan; 384(1):123-132. PubMed ID: 35779862
[TBL] [Abstract][Full Text] [Related]
24. Challenges in Using Circulating Micro-RNAs as Biomarkers for Cardiovascular Diseases.
Felekkis K; Papaneophytou C
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31952319
[TBL] [Abstract][Full Text] [Related]
25. Circulating MicroRNAs: Valuable Biomarkers for the Diagnosis and Prognosis of Gastric Cancer.
Shekari N; Baradaran B; Shanehbandi D; Kazemi T
Curr Med Chem; 2018 Feb; 25(6):698-714. PubMed ID: 28971758
[TBL] [Abstract][Full Text] [Related]
26. MicroRNAs in Atrial Fibrillation: from Expression Signatures to Functional Implications.
van den Berg NWE; Kawasaki M; Berger WR; Neefs J; Meulendijks E; Tijsen AJ; de Groot JR
Cardiovasc Drugs Ther; 2017 Jun; 31(3):345-365. PubMed ID: 28752208
[TBL] [Abstract][Full Text] [Related]
27. MiR-222 in Cardiovascular Diseases: Physiology and Pathology.
Ding S; Huang H; Xu Y; Zhu H; Zhong C
Biomed Res Int; 2017; 2017():4962426. PubMed ID: 28127557
[TBL] [Abstract][Full Text] [Related]
28. miRNAs as potential therapeutic targets and diagnostic biomarkers for cardiovascular disease with a particular focus on WO2010091204.
Yang Y; Yu T; Jiang S; Zhang Y; Li M; Tang N; Ponnusamy M; Wang JX; Li PF
Expert Opin Ther Pat; 2017 Sep; 27(9):1021-1029. PubMed ID: 28627982
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic, Prognostic, and Therapeutic Value of Circulating miRNAs in Heart Failure Patients Associated with Oxidative Stress.
Ali Sheikh MS; Salma U; Zhang B; Chen J; Zhuang J; Ping Z
Oxid Med Cell Longev; 2016; 2016():5893064. PubMed ID: 27379177
[TBL] [Abstract][Full Text] [Related]
30. microRNAs as promising biomarkers of platelet activity in antiplatelet therapy monitoring.
Krammer TL; Mayr M; Hackl M
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32423125
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA in cardiovascular biology and disease.
Wojciechowska A; Braniewska A; Kozar-Kamińska K
Adv Clin Exp Med; 2017 Aug; 26(5):865-874. PubMed ID: 29068585
[TBL] [Abstract][Full Text] [Related]
32. MicroRNAs Mediate Beneficial Effects of Exercise in Heart.
Bei Y; Tao L; Cretoiu D; Cretoiu SM; Xiao J
Adv Exp Med Biol; 2017; 1000():261-280. PubMed ID: 29098626
[TBL] [Abstract][Full Text] [Related]
33. Circulating miRNAs as biomarkers for early diagnosis of coronary artery disease.
Zhang L; Zhang Y; Zhao Y; Wang Y; Ding H; Xue S; Li P
Expert Opin Ther Pat; 2018 Aug; 28(8):591-601. PubMed ID: 30064285
[TBL] [Abstract][Full Text] [Related]
34. Recent progress toward the use of circulating microRNAs as clinical biomarkers.
Ghai V; Wang K
Arch Toxicol; 2016 Dec; 90(12):2959-2978. PubMed ID: 27585665
[TBL] [Abstract][Full Text] [Related]
35. Small RNAs have a large impact: circulating microRNAs as biomarkers for human diseases.
Weiland M; Gao XH; Zhou L; Mi QS
RNA Biol; 2012 Jun; 9(6):850-9. PubMed ID: 22699556
[TBL] [Abstract][Full Text] [Related]
36. Analysis of Serum MicroRNAs as Potential Biomarker in Coronary Bifurcation Lesion.
Liu Y; Chen S; Zhang J; Shan S; Chen L; Wang R; Kan J; Xu T
Dis Markers; 2015; 2015():351015. PubMed ID: 25999658
[TBL] [Abstract][Full Text] [Related]
37. Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease?
Creemers EE; Tijsen AJ; Pinto YM
Circ Res; 2012 Feb; 110(3):483-95. PubMed ID: 22302755
[TBL] [Abstract][Full Text] [Related]
38. MicroRNAs in cardiovascular disease: an introduction for clinicians.
Romaine SP; Tomaszewski M; Condorelli G; Samani NJ
Heart; 2015 Jun; 101(12):921-8. PubMed ID: 25814653
[TBL] [Abstract][Full Text] [Related]
39. The diagnostic and prognostic potential of plasma extracellular vesicles for cardiovascular disease.
Bank IE; Timmers L; Gijsberts CM; Zhang YN; Mosterd A; Wang JW; Chan MY; De Hoog V; Lim SK; Sze SK; Lam CS; De Kleijn DP
Expert Rev Mol Diagn; 2015; 15(12):1577-88. PubMed ID: 26535492
[TBL] [Abstract][Full Text] [Related]
40. MicroRNAs Determining Inflammation as Novel Biomarkers and Potential Therapeutic Targets.
Kotsinas A; Sigala F; Garbis SD; Galyfos G; Filis K; Vougas K; Papalampros A; Johnson EE; Chronopoulos E; Georgakilas AG; Gorgoulis VG
Curr Med Chem; 2015; 22(22):2666-79. PubMed ID: 26180004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
